Avista Corp. First Quarter 2025 Earnings Conference Call and Webcast Announced

(NYSE:AVA), SPOKANE, Wash., April 09, 2025 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) will hold its quarterly conference call and webcast to discuss first quarter 2025 results on Wednesday, May 7, 2025, at 12:30 p.m. Eastern Daylight Time. A news release with first quarter 2025 earnings information will be issued at 7:05 a.m. Eastern Daylight […]

Magnite to Announce First Quarter 2025 Financial Results on May 7, 2025

(NASDAQ:MGNI), NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Wednesday, May 7, 2025. The Company will host a conference call at 1:30 PM (PT) / 4:30 PM (ET)

SPX Technologies to Report First Quarter 2025 Financial Results

(NYSE:SPXC), CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) announced today that it will release its financial results for the first quarter of fiscal year 2025 after the U.S. financial markets close on Thursday, May 1, 2025. In conjunction with this announcement, SPX Technologies' President and Chief Executive Officer Gene Lowe

TTM Technologies, Inc. to Conduct First Quarter 2025 Conference Call on April 30, 2025

(NASDAQ:TTMI), SANTA ANA, Calif., April 09, 2025 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, April 30, 2025, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its first quarter 2025 performance. Access to the conference call will be available by clicking on the registration link TTM Technologies,

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences

Aggregate cash dividend of $69.6 million, or an estimated $2.40 per share Aerovate Therapeutics, Inc. (Nasdaq: AVTE) (“Aerovate”) today announced that its Board of Directors has declared a special cash dividend (the “Cash Dividend”) in connection with the previously announced merger (the “Merger”) with Jade Biosciences, Inc. (“Jade”) pursuant to the Agreement and Plan of

AB Announces March 31, 2025 Assets Under Management

AllianceBernstein L.P. (“AB”) and AllianceBernstein Holding L.P. (“AB Holding”) (NYSE: AB) today announced that preliminary assets under management decreased to $784 billion during March 2025 from $805 billion at the end of February. Net inflows across all three channels (Institutional, Retail and Private Wealth) were offset by market depreciation during March, resulting in a 2.6%

Mynd.ai Announces CEO Transition

Mynd.ai, Inc. (“Mynd” or the “Company”) (NYSE American: MYND), a global leader in interactive hardware and software solutions for education and enterprise, today announced that Vin Riera, Chief Executive Officer, will be stepping down from his role as CEO effective April 11, 2025, after eight years of exceptional leadership in the role. He has also

Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at HSMR Advisors, has been appointed to the Company's board of directors. Mr. van den Broek has more than 30 years of experience in the life

Lakeland Industries Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results

(NasdaqGM:LAKE), Q4'25 Net Sales Increased 49% to a Record $46.6 Million Led by a 226% Increase in Fire Services Products; FY 2025 Net Sales Increased 34% to $167.2 Million Q4'25 Gross Profit Increased 67% to $18.7 Million Due to Strong Organic Revenue Growth and Organic Mix Improvement Q4'25 Net Income Decreased to ($18.4) Due to

Scroll to Top